UK reimbursement authority NICE has recommended that the NHS in England can use AstraZeneca's Imfinzi as the first ...
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and ...
Medicines watchdog approves two treatments for patients with spinal muscular atrophy ...
A new UK drug approval pathway, designed to speed up the availability of new medicines, benefits industry over patients and ...
Pharmaceutical Technology on MSN
Imfinzi set to become first immunotherapy for stomach cancer patients on NHS
AstraZeneca’s targeted treatment helps patients live longer, along with preventing cancer recurrence.
The aligned pathway for UK drugs regulator MHRA and reimbursement authority NICE – aimed at slashing the time it takes for new medicines to reach patients – will start to deliver guidance in June, ...
Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.
However, after police uncovered detailed evidence of her involvement in supplying drugs as part of the murder probe, she ...
At least two people have been killed and several others injured after a gunman opened fire in the heart and capital of the ...
A new immunotherapy treatment for aggressive stomach cancer has been approved by the NHS spending watchdog. The National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results